Novo Nordisk A/S
Long
Updated

NVO bounce off of Ozempic launch AVWAP

234
Ozempic launched Feb 5 2018. Anchoring our VWAP to that date we get our confirmation of a strong anchor from the COVID bounce, indicating institutional buying at that level. Over 7 years later, we get another opportunity.

Note
I'm long at open tomorrow.
Trade active
Moving nicely to the 200 EMA, holding

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.